Mon, Aug 15, 2022 8:38 AM
STATS Perform dba Automated Insights
DUBLIN, Ohio (AP) _ Navidea Biopharmaceuticals Inc. (NAVB) on Monday reported a loss of $3 million in its second quarter.
On a per-share basis, the Dublin, Ohio-based company said it had a loss of 10 cents.
The biopharmaceutical posted revenue of $57,500 in the period. Its adjusted revenue was $58,000.